Its important to understand that meaningful and sustained weight loss usually develops over time with consistent weekly dosing and healthy lifestyle habits
If this same drug also receives FDA approval to treat diabetes or reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight, then it would be considered a Part D drug for those specific uses only Nothing has changed about the underlying rules, but as noted above, some GLP-1 medications have since received FDA approval to treat other medical conditions
Mandal D, Moitra PK, Saha S, Basu J
Isaac Glatstein works with patients to choose a timeline that balances medication safety with fertility goals, rather than stopping treatment suddenly at the last minute
Clearly the brain/central nervous system effect of these drugs is gaining traction and considerable interest